4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-22-003054
Options or other derivatives
- Chief Financial Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-28 | Grant or award : show line 1 in the form Restricted Stock Units | +250,000 | 681,000 | D |
Loading xslF345X03/ownership.xml…